Skip to main content
Download PDF

Cannabinoids and pain management

Les cannabinoïdes et le contrôle de la douleur

Canadian Journal of Anesthesia volume 53, Article number: 743 (2006) Cite this article

References

  1. Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964; 86:1646–7.

    Article  CAS  Google Scholar 

  2. Pertwee RG, Ross RA. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 2002; 66:101–21.

    PubMed  Article  CAS  Google Scholar 

  3. Lynch ME. Preclinical science regarding cannabinoids as analgesics: an overview. Pain Res Manag 2005; 10(SupplA):7A-14A.

    PubMed  Google Scholar 

  4. Walker JM, Strangman NM, Huang SM. Cannabinoids and pain. Pain Res Manag 2001; 6:74–9.

    PubMed  CAS  Google Scholar 

  5. Beaulieu P. Effects of nabilone, a synthetic cannabinoid, on postoperative pain. Can J Anesth 2006; 53:769–75.

    PubMed  Article  Google Scholar 

  6. Jain AK, Ryan JR, McMahon FG, Smith G. Evaluation of intramuscular levonantradol and placebo in acute postoperative pain. J Clin Pharmacol 1981; 21(8-9Suppl):320S-6S.

    PubMed  CAS  Google Scholar 

  7. Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001; 323:13–6.

    PubMed  Article  CAS  Google Scholar 

  8. Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 2004; 329:253.

    PubMed  Article  CAS  Google Scholar 

  9. Zajicek J, Fox P, Sanders H, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre rendomised placebo-controlled trial. Lancet 2003; 362:1517–26.

    PubMed  Article  CAS  Google Scholar 

  10. Zajicek JP, Sanders HP, Wright DE, et al. Cannabinoids in multiple sclerosis (CAMS) study:safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry 2005; 76:1664–9.

    PubMed  Article  CAS  Google Scholar 

  11. Berman JS, Symonds C, Birch R. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 2004; 112:299–306.

    PubMed  Article  Google Scholar 

  12. Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005; 65:812–9.

    PubMed  Article  Google Scholar 

  13. Lynch ME, Watson CP. The pharmacotherapy of chronic pain: a review. Pain Res Manag 2006; 11:11–38.

    PubMed  Google Scholar 

  14. Ware MA, Doyle CR, Woods R, Lynch ME, Clark AJ. Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain 2003; 102:211–6.

    PubMed  Article  Google Scholar 

  15. Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME. Patterns of cannabis use among patients with multiple sclerosis. Neurology 2004; 62:2098–2100.

    PubMed  Article  CAS  Google Scholar 

  16. Ogborne AC, Smart RG. Cannabis users in the general Canadian population. Subst Use Misuse 2000; 35:301–11.

    PubMed  Article  CAS  Google Scholar 

  17. Ogborne AC, Smart RG, Weber T, Birchmore-Tmney C. Who is using cannabis as a medicine and why: an exploratory study. J Psychoactive Drugs 2000; 32:435–43.

    PubMed  CAS  Google Scholar 

  18. Burstein SH. The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential. Pharmacol Ther 1999; 82:87–96.

    PubMed  Article  CAS  Google Scholar 

  19. Sumariwalla PF, Gallily L, Tchilibon S, Fride E, echoulam R, Feldmann M. A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis. Arthritis Rheum 2004; 50:985–98.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Anesthesia, Queen Elizabeth II Health Sciences Centre, Victoria General Hospital, 1278 Tower Rd., B3H 3L1, Halifax, Nova Scotia, Canada

    Orlando Hung

  2. Surgery, and Pharmacology, Dalhousie University, Halifax, Nova Scotia

    Orlando Hung

  3. Departments of Psychiatry, Anesthesia and Pharmacology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia

    Mary E. Lynch

  4. Department of Anesthesia, University of Calgary, Calgary Health Region, Calgary, Alberta, Canada

    Alexander J. Clark

Authors
  1. Orlando Hung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary E. Lynch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander J. Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Orlando Hung.

Additional information

Disclosure statement: Dr. Orlando Hung has filed patents for cannabinoid delivery systems in US and PCT.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hung, O., Lynch, M.E. & Clark, A.J. Cannabinoids and pain management. Can J Anesth 53, 743 (2006). https://doi.org/10.1007/BF03022788

Download citation

  • DOI: https://doi.org/10.1007/BF03022788